Nebivolol 1 A Pharma (Nebivolol Hydrochloride)

Nebivolol, the active ingredient in Nebivolol 1 A Pharma, is a beta blocker presented as a tablet for oral use. It is used to treat hypertension and heart failure in adult patients. GNH USA supplies Nebivolol 1 A Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol is indicated for cardiovascular conditions that involve elevated blood pressure or impaired cardiac function. - Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Heart failure with reduced ejection fraction: improves symptoms, exercise tolerance and reduces hospitalization. - Chronic stable heart failure: supports ventricular function and may delay disease progression.

Nebivolol may cause a range of adverse reactions.

Common Side Effects: - Headache: mild to moderate intensity. - Dizziness or light‑headedness, especially on standing. - Fatigue or tiredness during initial therapy. - Nausea or mild gastrointestinal upset. - Bradycardia: heart rate below normal limits. - Peripheral edema: swelling of lower limbs.

Serious or Rare Side Effects: - Severe bradycardia or heart block requiring medical attention. - Marked hypotension leading to syncope. - Bronchospasm in patients with reactive airway disease. - Allergic reactions such as rash, itching or angioedema. - Hepatic dysfunction indicated by elevated liver enzymes. - Acute heart failure exacerbation.

Before initiating nebivolol therapy, consider the following safety measures. - Blood pressure monitoring: ensure adequate control and avoid excessive drops. - Heart rate assessment: avoid use in patients with baseline severe bradycardia. - Respiratory caution: use carefully in asthma or COPD due to potential bronchoconstriction. - Discontinuation: taper gradually to prevent rebound hypertension. - Renal/hepatic impairment: dose adjustment may be required in moderate to severe dysfunction. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nebivolol can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Other β‑blockers: additive bradycardia and hypotension. - Calcium‑channel blockers (verapamil, diltiazem): increased plasma levels and risk of heart block. - Antiarrhythmic agents (e.g., amiodarone): may potentiate cardiac conduction delays.

Moderate Interactions (Monitor Closely): - Clonidine withdrawal: abrupt cessation can cause rebound hypertension. - Insulin or oral hypoglycemics: nebivolol may mask hypoglycemia symptoms.